SRI Sarnoff receives Lenel factory certification for IOM N-Glance identification system

NewsGuard 100/100 Score

SRI Sarnoff's Iris on the Move® N-Glance™ identification system has received Lenel factory certification for its interface to Lenel's OnGuard® software system. SRI is now a member of the Lenel OpenAccess Alliance Program. This certification validates SRI's IOM N-Glance as a biometric product for Lenel access control systems.

"SRI Sarnoff has completed the required factory testing at Lenel to validate the functionality of its interface to OnGuard," said Gidon Lissai, director of strategic alliances, Lenel. "We look forward to their continued involvement in the Lenel OpenAccess Alliance Program."

SRI's IOM N-Glance biometric identification and verification system is easy to use and unobtrusive. Users simply glance at the system from a comfortable distance without having to place their eye close to the camera. The system performs identification in less than a second, and can process up to 12 people per minute. It can also capture iris images even if a user is wearing eyeglasses or contact lenses.

"SRI Sarnoff is proud to receive Lenel's certification, as it is an important validation of our biometric product. Integration with OnGuard will enable SRI Sarnoff to offer products that meet the needs of value-added resellers (VARS) biometric requirements," said Mark Clifton, vice president, Products and Services Division at SRI Sarnoff.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revvity Signals Software unveils Signals Clinical solution to accelerate critical clinical trial insights and data-driven decisions